Mark J. Foley - Jun 30, 2024 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
CEO, Director
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Jun 30, 2024
Transactions value $
$2,185
Form type
4
Date filed
7/2/2024, 05:47 PM
Previous filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Award $2.18K +1K +0.1% $2.18 996K Jun 30, 2024 Direct F1
holding RVNC Common Stock 111K Jun 30, 2024 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired by Mr. Foley under the Issuer's 2014 Employee Stock Purchase Plan on June 30,2024 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 These shares are held by the Mark and Dana Foley, Trustees, Foley Family Trust U/A DTD 4/10/2002.